Newsbenzinga
Outlook Therapeutics Launches Underwritten Public Offering Of Common Stock And Warrants To Fund LYTENAVA Launch; No Financial Terms Disclosed
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…